文献速递主动脉疾病

新型慢性晚期腹主动脉瘤小鼠模型的建立

A novel chronic advanced stage abdominal aortic aneurysm murine model.
PubMed 文献 · J Vasc Surg · 2017-03-06

BAPN+弹性蛋白酶组AAA形成率93%高于弹性蛋白酶组的65%(P<.01),并表现出持续长期增长、血栓形成(54%)和破裂(31%)。结论为口服BAPN联合主动脉周围弹性蛋白酶应用可诱导慢性晚期AAA。

要点

  • BAPN+弹性蛋白酶组AAA形成率93%,高于弹性蛋白酶组的65%(P<.01)。
  • BAPN+弹性蛋白酶组晚期AAA(II和III期)比例更高(25/42 vs 1/40,P<.001)。
  • 该模型呈现持续增长、血栓形成(54%)和自发性破裂(31%)等晚期特征。

核心结论

  • 口服BAPN联合主动脉周围弹性蛋白酶应用可诱导慢性晚期腹主动脉瘤,具有持续增长、血栓形成和自发性破裂特征。

研究设计与样本

  • BAPN组术前2天起给予0.2% BAPN饮水至研究结束,并施行热灭活弹性蛋白酶假手术。
  • 弹性蛋白酶组给予常规饮水,术中以5 μL活性弹性蛋白酶(10.3 mg蛋白/mL,5.9 U/mg蛋白)作用于肾下腹主动脉外膜5分钟。
  • BAPN+弹性蛋白酶组给予BAPN饮水并应用活性弹性蛋白酶,术后第7、14、21、28和100天采集主动脉样本。

主要发现

  • BAPN+弹性蛋白酶组AAA形成率93%,高于弹性蛋白酶组的65%(P<.01)。
  • BAPN+弹性蛋白酶组II和III期AAA为25/42,弹性蛋白酶组为1/40(P<.001)。
  • BAPN+弹性蛋白酶组动脉瘤持续增长,第21、28和100天分别为221.5%±36.6%、285.8%±78.6%和801%±160%(P<.001)。
  • BAPN+弹性蛋白酶组晚期AAA中血栓形成占54%,破裂占31%。
  • BAPN+弹性蛋白酶组第7天多种细胞因子水平高于弹性蛋白酶组,第7天后除MMP-2活性升高外其余细胞因子回落至基线。

临床怎么用

  • 该模型可用于研究腹主动脉瘤晚期发展阶段的组织重塑机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to establish a reliable, chronic model of abdominal aortic aneurysm (AAA). METHODS: Wild-type 8-week-old C56BL/6 male mice (n = 120) were equally divided into three groups: (1) BAPN group: 0.2% 3-aminopropionitrile fumarate salt (BAPN) drinking water was provided to mice 2 days before surgery until the end of study. Sham aneurysm induction surgery was performed using 5 μL of heat deactivated elastase. (2) Elastase group: mice were given regular drinking water without BAPN. During aneurysm induction surgery, 5 μL of the active form of elastase (10.3 mg protein/mL, 5.9 U/mg protein) was applied on top of the infrarenal abdominal aorta adventitia for 5 minutes. (3) BAPN+elastase group: mice were given BAPN drinking water and the active form of elastase application, as above. On postoperative days 7, 14, 21, 28, and 100, aortic samples were collected for histology, cytokine array, and gelatin zymography after aortic diameter measurement. RESULTS: Compared with the elastase group, the BAPN+elastase group had a higher AAA formation rate (93% vs 65%; P < .01) with more advanced AAAs (25 of 42 vs 1 of 40 for stage II and III; P < .001). Aneurysms from the BAPN+elastase group demonstrated persistent long-term growth (221.5% ± 36.6%, 285.8% ± 78.6%, and 801% ± 160% on days 21, 28, and 100, respectively; P < .001), with considerable thrombus formation (54%) and rupture (31%) at the advanced stages of AAA development. Cytokine levels (pro-matrix metalloproteinase 9, interleukin-1β, interleukin-6, chemokine [C-C motif] ligand 5, triggering receptor expressed on myeloid cells 1, monocyte chemotactic protein 1, and tissue inhibitor of metalloproteinase 1) in the BAPN+elastase group were higher than in the elastase group on day 7. After day 7, cytokine levels returned to baseline, with the exception of elevated matrix metalloproteinase 2 activity. By histology, CD3-positive T cells in the BAPN+elastase group were elevated on days 28 and 100. CONCLUSIONS: A combination of oral BAPN administration and periaortic elastase application induced a chronic, advanced-stage AAA with characteristics of persistent aneurysm growth, thrombus formation, and spontaneous rupture. Future studies should use this model, especially for examining tissue remodeling during the late stages of aneurysm development.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lu G, Su G, Davis JP, et al. A novel chronic advanced stage abdominal aortic aneurysm murine model. J Vasc Surg. 2017. PMID: 28274752. doi:10.1016/j.jvs.2016.07.105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。